CABENUVA
CABENUVA
Approved
DIN Number
02497220
Drug Class
Human
Market Date
Sep 21, 2020
Company
HC
viiv healthcare ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02497220
AIG Number0262115001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS
Product Specifications
Dosage FormKit
,
Suspension (Extended-Release)
Route of AdministrationIntramuscular
AHFS Classification08:18.08.12
Health Canada Classification
ACTIVE INGREDIENTS (2)
CABOTEGRAVIRActive
Strength: 200 MG / ML
Monograph: CABOTEGRAVIR
RILPIVIRINEActive
Strength: 300 MG / ML
Monograph: RILPIVIRINE